{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T11:22:54Z","timestamp":1721733774698},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"crossref"}]},{"name":"JSPS KAKENHI","award":["16K08289"],"award-info":[{"award-number":["16K08289"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejphar.2017.01.028","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T17:15:56Z","timestamp":1485018956000},"page":"105-112","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Topical ocular treatment with monoclonal antibody Fab fragments targeting Japanese cedar pollen Cry j 1 inhibits Japanese cedar pollen-induced allergic conjunctivitis in mice"],"prefix":"10.1016","volume":"798","author":[{"given":"Nobuaki","family":"Mizutani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2017.01.028_bib1","first-page":"969","article-title":"Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials","volume":"151","author":"Abramson","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejphar.2017.01.028_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.iac.2007.12.005","article-title":"Allergic conjunctivitis","volume":"28","author":"Bielory","year":"2008","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.ejphar.2017.01.028_bib3","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S0011-393X(97)80049-5","article-title":"Current therapy of allergic conjunctivitis","volume":"58","author":"Bisca","year":"1997","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.ejphar.2017.01.028_bib4","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1398-9995.2006.01205.x","article-title":"Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method","volume":"61","author":"Calamita","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.ejphar.2017.01.028_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaci.2014.01.007","article-title":"Immunotherapy: what lies beyond","volume":"133","author":"Casale","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2017.01.028_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12325-013-0026-3","article-title":"Efficacy and safety of certolizumab pegol for Crohn's disease: a systematic review and meta-analysis","volume":"30","author":"Da","year":"2013","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejphar.2017.01.028_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s40265-013-0009-3","article-title":"Certolizumab pegol: a review of its use in the management of rheumatoid arthritis","volume":"73","author":"Deeks","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2017.01.028_bib8","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jaci.2013.02.013","article-title":"Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison","volume":"131","author":"Dretzke","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2017.01.028_bib9","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1365-2222.2009.03448.x","article-title":"Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic\/rhinitis children sensitized to house dust mite: an open randomized controlled trial","volume":"40","author":"Eifan","year":"2010","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2017.01.028_bib10","first-page":"5","article-title":"Current concepts in ocular allergy","volume":"67","author":"Friedlaender","year":"1991","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.ejphar.2017.01.028_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0091-6749(98)70023-5","article-title":"Eosinophil surface antigen expression and cytokine production vary in different ocular allergic diseases","volume":"102","author":"Hingorani","year":"1998","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2017.01.028_bib12","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1128\/JVI.02200-07","article-title":"Structure of antibody-neutralized murine norovirus and unexpected differences from viruslike particles","volume":"82","author":"Katpally","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.ejphar.2017.01.028_bib13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jaci.2011.04.033","article-title":"A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes","volume":"128","author":"Keles","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejphar.2017.01.028_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0161-6420(02)01767-0","article-title":"Tear and mucus eotaxin-1 and eotaxin-2 in allergic keratoconjunctivitis","volume":"110","author":"Leonardi","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejphar.2017.01.028_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.imlet.2014.06.005","article-title":"Allergen-specific regulation of allergic rhinitis in mice by intranasal exposure to IgG1 monoclonal antibody Fab fragments against pathogenic allergen","volume":"161","author":"Matsuoka","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ejphar.2017.01.028_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1081-1206(10)62726-3","article-title":"Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma \u2013 a placebo controlled study","volume":"82","author":"Mungan","year":"1999","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ejphar.2017.01.028_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/ibd.20225","article-title":"Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents","volume":"13","author":"Nesbitt","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2017.01.028_bib18","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1365-2222.2010.03688.x","article-title":"Specific immunotherapy in asthma: efficacy and safety","volume":"41","author":"Passalacqua","year":"2011","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2017.01.028_bib19","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.rmed.2009.01.008","article-title":"Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy","volume":"103","author":"Pipet","year":"2009","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejphar.2017.01.028_bib20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2016.03.020","article-title":"Topical skin treatment with Fab fragments of an allergen-specific IgG1 monoclonal antibody suppresses allergen-induced atopic dermatitis-like skin lesions in mice","volume":"779","author":"Sae-Wong","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2017.01.028_bib21","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4049\/jimmunol.148.7.2103","article-title":"Induction of arthritis with monoclonal antibodies to collagen","volume":"148","author":"Terato","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2017.01.028_bib22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/imm.12225","article-title":"Intratracheal exposure to Fab fragments of allergen specific monoclonal antibody regulates asthmatic responses in mice","volume":"141","author":"Yoshino","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.ejphar.2017.01.028_bib23","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/bph.13463","article-title":"Intranasal exposure to monoclonal antibody Fab fragments to Japanese cedar pollen Cry j1 suppresses Japanese cedar pollen-induced allergic rhinitis","volume":"173","author":"Yoshino","year":"2016","journal-title":"Br. J. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917300389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299917300389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T21:52:06Z","timestamp":1692654726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299917300389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":23,"alternative-id":["S0014299917300389"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.01.028","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical ocular treatment with monoclonal antibody Fab fragments targeting Japanese cedar pollen Cry j 1 inhibits Japanese cedar pollen-induced allergic conjunctivitis in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2017.01.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}